Applied Clinical Trials
Navigating the many complexities in clinical trials, manufacturing, and regulatory interaction in moving gene therapies from development to market.
David Shoemaker, PhD
Advertisement
Articles by David Shoemaker, PhD
Applied Clinical Trials
A regulatory perspective on the current state of protein science and the implications for biosimilar approval.
Advertisement
Latest Updated Articles
The U.S. Biosimilar Pathway: Policy Precedes ScienceJune 1st 2015
The Gene Therapy Product Development ProcessJuly 1st 2019
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
2
ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery
3
Two Decades of Rising Protocol Complexity: A Longitudinal Analysis of Clinical Trial Design Evolution, 2004–2025
4
ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle
5